Genzyme Takes Bayer to Relieve Headache of Entering Seattle Biotech Hub

SUGAR LAND--April 15, 2009--Researched by Industrial Info Resources (Sugar Land, Texas)--Genzyme (NASDAQ:GENZ) (Cambridge, Massachusetts), arguably the world's largest maker of drugs for genetic diseases, has entered into a strategic alliance with Bayer AG (OTC:BAYRY) (Leverkusen, Germany), by obtaining three of its oncology product lines: Campath, Fludara and Leukine. One drug in particular, Leukine, will allow Genzyme to make its first foray into the Seattle Biotech Market.